ANDA 83347, held by Impax Labs. Quinidine Sulfate.
As of Nov 16, 2026, ANDA 83347 (Quinidine Sulfate), held by Impax Labs, was first approved by FDA on Dec 8, 1976, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate200MG ยท tablet;oral | Quinidine Sulfate | Discontinued |
| Feb 21, 2001 | Supplement 26Labeling | Approved | None posted |
| Feb 28, 1990 | Supplement 29Labeling | Approved | None posted |
| Feb 28, 1990 | Supplement 30Labeling | Approved | None posted |
| Dec 23, 1988 | Supplement 28Labeling | Approved | None posted |
| Nov 23, 1988 | Supplement 27Labeling | Approved | None posted |
| Dec 8, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters